INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 416m ago
HOUSE PTR15m ago
SEC 13F15m ago
ROBINHOOD CHAIN15m ago
Public company

ANLAdlai Nortye Group Ltd.

CIK 0001944552

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 7
Max Insider Score31
Connections4with evidence

ANL · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
JP
Ji PingDirector
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL$80K
5,000 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Ye XiaofengCFO · Aug 26, 2026
  • ← Insider ofevidence
    Ji PingDirector · Jun 10, 2026
  • ← Insider ofevidence
    Lu YangDirector, CEO, 10% Owner · May 21, 2026
17
JP
Ji PingDirector
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL
$3,375
214 sh
Sep 29, 2026
Oct 1, 2026
traded Sep 29, 2026
+2d
SEC FORM 4

Evidence

20
JP
Ji PingDirector
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL$80K
5,000 sh
Sep 30, 2026Oct 1, 2026
traded Sep 30, 2026
+1dSEC FORM 4

Evidence

24
JP
Ji PingDirector
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL$83K
5,000 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

20
YX
Ye XiaofengCFO
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL$81K
5,667 sh
Aug 26, 2026Aug 26, 2026
traded Aug 26, 2026
+0dSEC FORM 4

Evidence

24
YX
Ye XiaofengCFO
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL$84K
6,000 sh
Aug 24, 2026Aug 26, 2026
traded Aug 24, 2026
+2dSEC FORM 4

Evidence

12
JP
Ji PingDirector
ANLAdlai Nortye Group Ltd.
Other acquisition or disposition
J—
136.7K sh
Jun 10, 2026Jun 10, 2026
traded Jun 10, 2026
+0dSEC FORM 4

Evidence

31
LY
Lu YangDirector, CEO, 10% Owner
ANLAdlai Nortye Group Ltd.
Open-market sale
SELL$132
10 sh
May 13, 2026May 21, 2026
traded May 13, 2026
+8dSEC FORM 4

Evidence